-Presentation to be Webcast-
MONTVALE, N.J., Oct. 30 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (Amex: SYI) announced today that Noah Berkowitz, M.D., Ph.D. President and Chief Executive Officer of Synvista will present at the upcoming Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on Tuesday, November 6, 2007 at 3:20 p.m. Eastern Time. The event will be held from November 5-7, 2007 at the New York Palace Hotel in New York.
Dr. Berkowitz will discuss the company's planned and/or ongoing Phase 2 initiatives for ALT-2074 in cardiovascular diseases, and alagebrium in heart failure and diabetic nephropathy. He will also provide an update of recent milestones and executive appointments.
The presentation will be simultaneously webcast and can be viewed live on the investor relations section of the Company's website at http://www.synvista.com. Participants are encouraged to log on to the webcast approximately five to ten minutes prior to the start of the presentation. It will be archived there after the event.
Note to Attendees: Synvista will be available for one-on-one meetings. Please arrange through Acumen BioFin Rodman & Renshaw or by calling Emmanuelle Ferrer or Kim Sutton Golodetz at Lippert/Heilshorn & Associates at 212-838- 3777.
The conference will feature presentations from more than 350 public and
privately held emerging growth healthcare companies presenting data on an
array of therapeutic topics including oncology, cardiovascular disease,
central nervous system disorders, infectious diseases and medical device
technology. Details regarding the conference can be obtained at
|SOURCE Synvista Therapeutics, Inc.|
Copyright©2007 PR Newswire.
All rights reserved